INJECTION SITE SWELLING

This adverse event was reported 76698 times

These drugs are most commonly taken by patients reporting INJECTION SITE SWELLING:

# Drug Count
0 ETANERCEPT 23301
1 DUPILUMAB 12850
2 ADALIMUMAB 7876
3 METHOTREXATE SODIUM 3632
4 METHOTREXATE 3586
5 EVOLOCUMAB 2103
6 TIRZEPATIDE 1832
7 PREDNISONE 1812
8 GLATIRAMER ACETATE 1715
9 ERGOCALCIFEROL 1676
See all common drugs associated with INJECTION SITE SWELLING

INJECTION SITE SWELLING is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 ZOPAPOGENE IMADENOVEC 17 0.4250
1 BETAMETHASONE SODIUM PHOSPHATE AND BETAMETHASONE ACETATE 9 0.2045
2 DEOXYCHOLIC ACID 305 0.1307
3 SIBEPRENLIMAB 75 0.1089
4 PEGVALIASE-PQPZ 584 0.0686
5 GLATIRAMER ACETATE INJECTION 292 0.0620
6 ERGOCALCIFEROL 1676 0.0564
7 LENACAPAVIR SODIUM 24 0.0474
8 IXEKIZUMAB 1659 0.0445
9 RILONACEPT 50 0.0432
See all drugs enriched for association with INJECTION SITE SWELLING